HIV Drugs Flashcards

1
Q

Normal CD4 count? (range)

Copies of virus for the virus to be “suppressed”?

A

Normal: 800-1500 cells

Suppression: less than 50 copies/mL of the virus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How do NRTIs potentially cause lactic acidosis?

A

They block DNA-gamma, leading to dec. production of mitochondrial DNA W/o mitochondria the body depends on anaerobic synthesis, leading to lactic acidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What patients are contraindicated from using Abacavir/ why?

A

HLA-B 5701 patients because of a Hypersensitivity risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Contraindication for Zidovudine?

Drug interactions?

A

Contraindicated in pts on Stavudine (antagonistic)

Interactions:

Ganciclovir– BM toxicity

Ribavirin– Antagonist

Contrimoxazole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

MOA of NNRTIs

Resistance?

A

Noncompetively bind to RT and induce allosteric change, relaxing the enzyme function

You can develop resistance rapidly!!! (but it at least buys you time before using the PIs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the only NNRTI you can give with Rifampin?

A

Efavirenz

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Nevirapine vs Efavirenz

A
  1. Nevirapine is recommended as an alternative to Efavirenz in tx of naive women
  2. Nev. is severely hepatotoxic!
  3. Contraindications: women, CD4 < 250; men CD4 < 400
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Ritonavir

  1. Against against what?
  2. Main AE?
  3. Indication?
  4. Similar to what drug?
A
  1. Active against HIV-1 and HIV-2
  2. AE = paresthesias (pins and needles)
  3. NOT a good ARV, but very useful for boosting the efficacy of other PIs (it’s a CYP inhibitor), allowing for reduction of dose/dose freq.
  4. Similar to Cobicistat
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Statins can be useful in dealing w/ effects of metabolic syndrome from PIs, but you can’t use any that are CYP substrates.

Which Statins are OK to give with PIs? Which are not?

A
  1. OK: Pravastatin and Fluvastatin (no CYP met.)
  2. Not OK: Simvastatin, atorvastatin, lovastatin (CYP met.)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Trofile Assay purpose

A

Analyze potential resistance mechanisms and tell you which cell receptors (CCR5 or CXCR4) are prefered by the particular viral strain.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Who are CCR5 antagonist drugs particularly useful for?

A

Patients w/ viral suppression failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is our only injectable HIV med as of now?

A

Fusion inhibitor (enfuvirtide)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
  1. Function of Integrase
  2. MOA of integrase inhibitors
  3. What mutations lead to resistance?
A
  1. Integrase allows viral DNA to integrate with the host cell DNA
  2. Integrase inhibitors block integrase fxn by binding Mg2+ required for strand transfer
  3. Mutations that alter orientation of Mg2+ ions can be resistant to INTIs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Name the integrase inhibitors.

How do they differ?

A

Raltegavir: standard INTI.

Elvitegravir: Shortest half-life; CYP substrate (but still approved!)

Dolutegravir: Longest half-life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Standard skeleton for combination of ART for tx of naive patients

A
  1. (2) NRTIs + (1) NNRTI
  2. (2) NRTIs + (1) PI
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Preferred Dual- NRTI option

A

Tenofovir + Emtricitabine

17
Q

What are the alternative dual-NRTI options?

A

Abacavir + lamivudine

Didanosine + lamivudine (or emtricitabine)

Zidovudine + Lamivudine

18
Q
  1. Recommended NNRTI option?
  2. Alternate?
A
  1. Rec: Efavirenz
  2. Alt: Nevirapine (not in patients with hepatic impairment or too high of a CD4 count)
19
Q

Preferred PI options and contraindications (if there are)

A
  1. Atazanavir + Ritonavir (contra. in patients who require high dose Proton pump inhibitors)
  2. Darunavir + Ritonavir
  3. Fosamprenavir + Ritonavir
20
Q

Alternative PI options

A
  1. Unboosted atazanavir (except with tenofovir or didanosine/lamivudine)
  2. Fosamprenavir + RTV
  3. Saquinavir + ritonavir
21
Q

Why wouldn’t you use these drugs together? Note any exceptions.

Atazanavir + indinavir

A

Potential hyperbilirubinemia

22
Q

Why wouldn’t you use these drugs together? Note any exceptions.

Didanosine + Stavudine

A

High incidence of toxcity, potential serious lactic acidosis

Exception: when no other options are available

23
Q

Why wouldn’t you use these drugs together? Note any exceptions.

Double NNRTI combo

A

Efavirenz and Nevirapine have more AEs together than separately. Both also reduce ETV.

24
Q

Why wouldn’t you use this drug? Note any exceptions.

EFV in 1st trimester

A

Teratogenicity

Exception when no other option is available

25
Q

Why wouldn’t you use these drugs together? Note any exceptions.

Emtricitabine + lamivudine

A

Similar resistance profile

26
Q

Why wouldn’t you use these drugs together? Note any exceptions.

Etravirine + unboosted PI

A

Induced PI metabolism

27
Q

Why wouldn’t you use these drugs together? Note any exceptions.

Etravirine (ETV) + boosted ATV, FPV, or TPV

A

Induced PI metabolism

28
Q

Why wouldn’t you use this drug? Note any exceptions.

Nevirapine in naive women with CD4>250, men CD4 > 400

A

Hepatotoxicity

Exception when no other option is available

29
Q

Why wouldn’t you use these drugs together? Note any exceptions.

Stavudine + Zidovudine

A

Antagonistic

30
Q

Why wouldn’t you use these drugs? Note any exceptions.

Unboosted darunavir, saquinavir, or tipranavir

A

Inadequte bioavailability